New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – NORTHWEST BIOTHERAPEUTICS INC (0001072379) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – NORTHWEST BIOTHERAPEUTICS INC (0001072379) (Filer)
Filed: 2016-12-09 AccNo: 0001144204-16-138809 Size: 42 KB

Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-12-09T17:28:28-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1072379/000114420416138809/0001144204-16-138809-index.htm